nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—CYP1A2—Clobetasol propionate—psoriasis	0.118	0.323	CbGbCtD
Trifluoperazine—CYP1A2—Methoxsalen—psoriasis	0.0622	0.17	CbGbCtD
Trifluoperazine—ABCB1—Mycophenolate mofetil—psoriasis	0.0312	0.0851	CbGbCtD
Trifluoperazine—ABCB1—Betamethasone—psoriasis	0.0268	0.0731	CbGbCtD
Trifluoperazine—ABCB1—Prednisolone—psoriasis	0.0264	0.0721	CbGbCtD
Trifluoperazine—ABCB1—Hydrocortisone—psoriasis	0.0251	0.0683	CbGbCtD
Trifluoperazine—ABCB1—Prednisone—psoriasis	0.025	0.0681	CbGbCtD
Trifluoperazine—ABCB1—Cyclosporine—psoriasis	0.0237	0.0645	CbGbCtD
Trifluoperazine—S100A4—synovial membrane of synovial joint—psoriasis	0.0235	0.421	CbGeAlD
Trifluoperazine—ABCB1—Dexamethasone—psoriasis	0.0156	0.0425	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—psoriasis	0.0125	0.0341	CbGbCtD
Trifluoperazine—S100A4—skin of body—psoriasis	0.00468	0.0838	CbGeAlD
Trifluoperazine—HTR2A—vertebral column—psoriasis	0.0043	0.077	CbGeAlD
Trifluoperazine—S100A4—tendon—psoriasis	0.00356	0.0638	CbGeAlD
Trifluoperazine—S100A4—Isotretinoin—Acitretin—psoriasis	0.00324	0.166	CbGdCrCtD
Trifluoperazine—S100A4—Tretinoin—Acitretin—psoriasis	0.00324	0.166	CbGdCrCtD
Trifluoperazine—S100A4—Alitretinoin—Acitretin—psoriasis	0.00324	0.166	CbGdCrCtD
Trifluoperazine—CALM2—endothelium—psoriasis	0.00316	0.0565	CbGeAlD
Trifluoperazine—CALM1—endothelium—psoriasis	0.00314	0.0562	CbGeAlD
Trifluoperazine—TNNC1—tendon—psoriasis	0.003	0.0537	CbGeAlD
Trifluoperazine—S100A4—Calcipotriol—Calcitriol—psoriasis	0.0025	0.128	CbGdCrCtD
Trifluoperazine—S100A4—Calcipotriol—Cholecalciferol—psoriasis	0.00213	0.109	CbGdCrCtD
Trifluoperazine—HTR2A—endothelium—psoriasis	0.00191	0.0342	CbGeAlD
Trifluoperazine—CALM2—skin of body—psoriasis	0.00135	0.0241	CbGeAlD
Trifluoperazine—CALM1—skin of body—psoriasis	0.00134	0.024	CbGeAlD
Trifluoperazine—CALM3—tendon—psoriasis	0.00131	0.0234	CbGeAlD
Trifluoperazine—SIGMAR1—tendon—psoriasis	0.00117	0.0209	CbGeAlD
Trifluoperazine—CALM2—tendon—psoriasis	0.00103	0.0184	CbGeAlD
Trifluoperazine—CALM1—tendon—psoriasis	0.00102	0.0183	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Clobetasol propionate—psoriasis	0.000919	0.0469	CbGdCrCtD
Trifluoperazine—HRH1—tendon—psoriasis	0.000745	0.0133	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Fluocinonide—psoriasis	0.000736	0.0376	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Beclomethasone—psoriasis	0.000736	0.0376	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.000715	0.0365	CbGdCrCtD
Trifluoperazine—HTR2A—tendon—psoriasis	0.000622	0.0111	CbGeAlD
Trifluoperazine—Decreased appetite—Hydroxyurea—psoriasis	0.000597	0.00143	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—psoriasis	0.000596	0.00143	CcSEcCtD
Trifluoperazine—Cardiac arrest—Prednisone—psoriasis	0.000595	0.00143	CcSEcCtD
Trifluoperazine—Fatigue—Hydroxyurea—psoriasis	0.000592	0.00142	CcSEcCtD
Trifluoperazine—Constipation—Hydroxyurea—psoriasis	0.000587	0.00141	CcSEcCtD
Trifluoperazine—Dry mouth—Mycophenolic acid—psoriasis	0.000587	0.00141	CcSEcCtD
Trifluoperazine—Nausea—Calcitriol—psoriasis	0.000584	0.0014	CcSEcCtD
Trifluoperazine—Dizziness—Acitretin—psoriasis	0.000578	0.00139	CcSEcCtD
Trifluoperazine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000577	0.00139	CcSEcCtD
Trifluoperazine—Weight increased—Betamethasone—psoriasis	0.000565	0.00136	CcSEcCtD
Trifluoperazine—Weight increased—Dexamethasone—psoriasis	0.000565	0.00136	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Dexamethasone—psoriasis	0.00056	0.00135	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Betamethasone—psoriasis	0.00056	0.00135	CcSEcCtD
Trifluoperazine—Skin disorder—Mycophenolic acid—psoriasis	0.000559	0.00134	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000554	0.00133	CcSEcCtD
Trifluoperazine—Nervousness—Cyclosporine—psoriasis	0.000554	0.00133	CcSEcCtD
Trifluoperazine—Muscular weakness—Prednisone—psoriasis	0.000552	0.00133	CcSEcCtD
Trifluoperazine—Rash—Acitretin—psoriasis	0.000551	0.00132	CcSEcCtD
Trifluoperazine—Dermatitis—Acitretin—psoriasis	0.000551	0.00132	CcSEcCtD
Trifluoperazine—Rash—Fluocinolone Acetonide—psoriasis	0.00055	0.00132	CcSEcCtD
Trifluoperazine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000549	0.00132	CcSEcCtD
Trifluoperazine—Anorexia—Mycophenolic acid—psoriasis	0.000548	0.00132	CcSEcCtD
Trifluoperazine—Muscle spasms—Cyclosporine—psoriasis	0.000548	0.00132	CcSEcCtD
Trifluoperazine—Headache—Acitretin—psoriasis	0.000548	0.00132	CcSEcCtD
Trifluoperazine—Headache—Fluocinolone Acetonide—psoriasis	0.000546	0.00131	CcSEcCtD
Trifluoperazine—Body temperature increased—Hydroxyurea—psoriasis	0.000543	0.0013	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—psoriasis	0.00054	0.0013	CcSEcCtD
Trifluoperazine—Nervousness—Mycophenolate mofetil—psoriasis	0.00054	0.0013	CcSEcCtD
Trifluoperazine—Hypotension—Mycophenolic acid—psoriasis	0.000537	0.00129	CcSEcCtD
Trifluoperazine—Vision blurred—Cyclosporine—psoriasis	0.000537	0.00129	CcSEcCtD
Trifluoperazine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000535	0.00128	CcSEcCtD
Trifluoperazine—Tremor—Cyclosporine—psoriasis	0.000534	0.00128	CcSEcCtD
Trifluoperazine—Agitation—Cyclosporine—psoriasis	0.000524	0.00126	CcSEcCtD
Trifluoperazine—Tremor—Mycophenolate mofetil—psoriasis	0.000521	0.00125	CcSEcCtD
Trifluoperazine—Angioedema—Cyclosporine—psoriasis	0.000521	0.00125	CcSEcCtD
Trifluoperazine—Insomnia—Mycophenolic acid—psoriasis	0.00052	0.00125	CcSEcCtD
Trifluoperazine—Nausea—Acitretin—psoriasis	0.000519	0.00125	CcSEcCtD
Trifluoperazine—Erythema—Prednisolone—psoriasis	0.000519	0.00125	CcSEcCtD
Trifluoperazine—Nausea—Fluocinolone Acetonide—psoriasis	0.000518	0.00124	CcSEcCtD
Trifluoperazine—Dyspnoea—Mycophenolic acid—psoriasis	0.000513	0.00123	CcSEcCtD
Trifluoperazine—Somnolence—Mycophenolic acid—psoriasis	0.000511	0.00123	CcSEcCtD
Trifluoperazine—Agitation—Mycophenolate mofetil—psoriasis	0.000511	0.00123	CcSEcCtD
Trifluoperazine—Leukopenia—Cyclosporine—psoriasis	0.00051	0.00123	CcSEcCtD
Trifluoperazine—Angioedema—Mycophenolate mofetil—psoriasis	0.000508	0.00122	CcSEcCtD
Trifluoperazine—Erythema—Hydrocortisone—psoriasis	0.000507	0.00122	CcSEcCtD
Trifluoperazine—Hypersensitivity—Hydroxyurea—psoriasis	0.000506	0.00122	CcSEcCtD
Trifluoperazine—Decreased appetite—Mycophenolic acid—psoriasis	0.0005	0.0012	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Prednisone—psoriasis	0.000498	0.0012	CcSEcCtD
Trifluoperazine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000498	0.0012	CcSEcCtD
Trifluoperazine—Cough—Cyclosporine—psoriasis	0.000497	0.00119	CcSEcCtD
Trifluoperazine—Fatigue—Mycophenolic acid—psoriasis	0.000496	0.00119	CcSEcCtD
Trifluoperazine—Convulsion—Cyclosporine—psoriasis	0.000494	0.00119	CcSEcCtD
Trifluoperazine—Asthenia—Hydroxyurea—psoriasis	0.000493	0.00118	CcSEcCtD
Trifluoperazine—Weight increased—Prednisone—psoriasis	0.000492	0.00118	CcSEcCtD
Trifluoperazine—Constipation—Mycophenolic acid—psoriasis	0.000492	0.00118	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisolone—psoriasis	0.000489	0.00117	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Prednisone—psoriasis	0.000488	0.00117	CcSEcCtD
Trifluoperazine—Cough—Mycophenolate mofetil—psoriasis	0.000485	0.00117	CcSEcCtD
Trifluoperazine—Convulsion—Mycophenolate mofetil—psoriasis	0.000482	0.00116	CcSEcCtD
Trifluoperazine—Erythema—Triamcinolone—psoriasis	0.000477	0.00115	CcSEcCtD
Trifluoperazine—Dry mouth—Cyclosporine—psoriasis	0.000475	0.00114	CcSEcCtD
Trifluoperazine—Angioedema—Prednisolone—psoriasis	0.000474	0.00114	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cyclosporine—psoriasis	0.000465	0.00112	CcSEcCtD
Trifluoperazine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000463	0.00111	CcSEcCtD
Trifluoperazine—Angioedema—Hydrocortisone—psoriasis	0.000463	0.00111	CcSEcCtD
Trifluoperazine—Body temperature increased—Mycophenolic acid—psoriasis	0.000455	0.00109	CcSEcCtD
Trifluoperazine—Dizziness—Hydroxyurea—psoriasis	0.000454	0.00109	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000454	0.00109	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—psoriasis	0.000452	0.00109	CcSEcCtD
Trifluoperazine—Skin disorder—Cyclosporine—psoriasis	0.000452	0.00109	CcSEcCtD
Trifluoperazine—Convulsion—Prednisolone—psoriasis	0.000449	0.00108	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—psoriasis	0.000448	0.00108	CcSEcCtD
Trifluoperazine—Anorexia—Cyclosporine—psoriasis	0.000443	0.00107	CcSEcCtD
Trifluoperazine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000441	0.00106	CcSEcCtD
Trifluoperazine—Convulsion—Hydrocortisone—psoriasis	0.000439	0.00105	CcSEcCtD
Trifluoperazine—Angioedema—Triamcinolone—psoriasis	0.000436	0.00105	CcSEcCtD
Trifluoperazine—Rash—Hydroxyurea—psoriasis	0.000433	0.00104	CcSEcCtD
Trifluoperazine—Erythema—Dexamethasone—psoriasis	0.000433	0.00104	CcSEcCtD
Trifluoperazine—Erythema—Betamethasone—psoriasis	0.000433	0.00104	CcSEcCtD
Trifluoperazine—Anorexia—Mycophenolate mofetil—psoriasis	0.000433	0.00104	CcSEcCtD
Trifluoperazine—Dermatitis—Hydroxyurea—psoriasis	0.000432	0.00104	CcSEcCtD
Trifluoperazine—Headache—Hydroxyurea—psoriasis	0.00043	0.00103	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—psoriasis	0.000429	0.00103	CcSEcCtD
Trifluoperazine—Hypotension—Mycophenolate mofetil—psoriasis	0.000424	0.00102	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisolone—psoriasis	0.000423	0.00102	CcSEcCtD
Trifluoperazine—Insomnia—Cyclosporine—psoriasis	0.000421	0.00101	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—psoriasis	0.000416	0.001	CcSEcCtD
Trifluoperazine—Cough—Triamcinolone—psoriasis	0.000416	0.001	CcSEcCtD
Trifluoperazine—Dyspnoea—Cyclosporine—psoriasis	0.000415	0.000996	CcSEcCtD
Trifluoperazine—Somnolence—Cyclosporine—psoriasis	0.000414	0.000994	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000413	0.000993	CcSEcCtD
Trifluoperazine—Convulsion—Triamcinolone—psoriasis	0.000413	0.000993	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—psoriasis	0.000413	0.000991	CcSEcCtD
Trifluoperazine—Asthenia—Mycophenolic acid—psoriasis	0.000413	0.000991	CcSEcCtD
Trifluoperazine—Insomnia—Mycophenolate mofetil—psoriasis	0.00041	0.000986	CcSEcCtD
Trifluoperazine—Nausea—Hydroxyurea—psoriasis	0.000408	0.00098	CcSEcCtD
Trifluoperazine—Pruritus—Mycophenolic acid—psoriasis	0.000407	0.000977	CcSEcCtD
Trifluoperazine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000405	0.000972	CcSEcCtD
Trifluoperazine—Decreased appetite—Cyclosporine—psoriasis	0.000404	0.000971	CcSEcCtD
Trifluoperazine—Somnolence—Mycophenolate mofetil—psoriasis	0.000403	0.000969	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—psoriasis	0.000403	0.000968	CcSEcCtD
Trifluoperazine—Skin disorder—Hydrocortisone—psoriasis	0.000402	0.000965	CcSEcCtD
Trifluoperazine—Fatigue—Cyclosporine—psoriasis	0.000401	0.000963	CcSEcCtD
Trifluoperazine—Constipation—Cyclosporine—psoriasis	0.000398	0.000956	CcSEcCtD
Trifluoperazine—Dry mouth—Triamcinolone—psoriasis	0.000397	0.000954	CcSEcCtD
Trifluoperazine—Angioedema—Betamethasone—psoriasis	0.000395	0.00095	CcSEcCtD
Trifluoperazine—Angioedema—Dexamethasone—psoriasis	0.000395	0.00095	CcSEcCtD
Trifluoperazine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000394	0.000948	CcSEcCtD
Trifluoperazine—Anorexia—Hydrocortisone—psoriasis	0.000394	0.000947	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Triamcinolone—psoriasis	0.000389	0.000935	CcSEcCtD
Trifluoperazine—Constipation—Mycophenolate mofetil—psoriasis	0.000388	0.000932	CcSEcCtD
Trifluoperazine—Hypotension—Hydrocortisone—psoriasis	0.000386	0.000928	CcSEcCtD
Trifluoperazine—Insomnia—Prednisolone—psoriasis	0.000383	0.00092	CcSEcCtD
Trifluoperazine—Dizziness—Mycophenolic acid—psoriasis	0.00038	0.000913	CcSEcCtD
Trifluoperazine—Erythema—Prednisone—psoriasis	0.000377	0.000905	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—psoriasis	0.000376	0.000904	CcSEcCtD
Trifluoperazine—Convulsion—Betamethasone—psoriasis	0.000375	0.000901	CcSEcCtD
Trifluoperazine—Convulsion—Dexamethasone—psoriasis	0.000375	0.000901	CcSEcCtD
Trifluoperazine—Insomnia—Hydrocortisone—psoriasis	0.000374	0.000898	CcSEcCtD
Trifluoperazine—Urticaria—Cyclosporine—psoriasis	0.00037	0.000888	CcSEcCtD
Trifluoperazine—Body temperature increased—Cyclosporine—psoriasis	0.000368	0.000883	CcSEcCtD
Trifluoperazine—Rash—Mycophenolic acid—psoriasis	0.000363	0.000871	CcSEcCtD
Trifluoperazine—Dermatitis—Mycophenolic acid—psoriasis	0.000362	0.00087	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Hydrocortisone—psoriasis	0.000361	0.0184	CbGdCrCtD
Trifluoperazine—Urticaria—Mycophenolate mofetil—psoriasis	0.000361	0.000866	CcSEcCtD
Trifluoperazine—Headache—Mycophenolic acid—psoriasis	0.00036	0.000865	CcSEcCtD
Trifluoperazine—Decreased appetite—Hydrocortisone—psoriasis	0.000359	0.000863	CcSEcCtD
Trifluoperazine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000359	0.000862	CcSEcCtD
Trifluoperazine—Fatigue—Hydrocortisone—psoriasis	0.000356	0.000856	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisone—psoriasis	0.000355	0.000853	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Dexamethasone—psoriasis	0.000353	0.000849	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Betamethasone—psoriasis	0.000353	0.000849	CcSEcCtD
Trifluoperazine—Insomnia—Triamcinolone—psoriasis	0.000352	0.000846	CcSEcCtD
Trifluoperazine—Dyspnoea—Triamcinolone—psoriasis	0.000347	0.000834	CcSEcCtD
Trifluoperazine—Agitation—Prednisone—psoriasis	0.000346	0.000832	CcSEcCtD
Trifluoperazine—Angioedema—Prednisone—psoriasis	0.000344	0.000827	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cyclosporine—psoriasis	0.000343	0.000823	CcSEcCtD
Trifluoperazine—Nausea—Mycophenolic acid—psoriasis	0.000342	0.000821	CcSEcCtD
Trifluoperazine—Anorexia—Dexamethasone—psoriasis	0.000337	0.000809	CcSEcCtD
Trifluoperazine—Anorexia—Betamethasone—psoriasis	0.000337	0.000809	CcSEcCtD
Trifluoperazine—Urticaria—Prednisolone—psoriasis	0.000336	0.000808	CcSEcCtD
Trifluoperazine—Fatigue—Triamcinolone—psoriasis	0.000336	0.000806	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Betamethasone—psoriasis	0.000336	0.0171	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Dexamethasone—psoriasis	0.000336	0.0171	CbGdCrCtD
Trifluoperazine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000334	0.000803	CcSEcCtD
Trifluoperazine—Asthenia—Cyclosporine—psoriasis	0.000334	0.000802	CcSEcCtD
Trifluoperazine—Hypotension—Betamethasone—psoriasis	0.00033	0.000793	CcSEcCtD
Trifluoperazine—Hypotension—Dexamethasone—psoriasis	0.00033	0.000793	CcSEcCtD
Trifluoperazine—Pruritus—Cyclosporine—psoriasis	0.000329	0.000791	CcSEcCtD
Trifluoperazine—Urticaria—Hydrocortisone—psoriasis	0.000328	0.000789	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Triamcinolone—psoriasis	0.000328	0.0167	CbGdCrCtD
Trifluoperazine—Body temperature increased—Hydrocortisone—psoriasis	0.000327	0.000785	CcSEcCtD
Trifluoperazine—Convulsion—Prednisone—psoriasis	0.000327	0.000785	CcSEcCtD
Trifluoperazine—Asthenia—Mycophenolate mofetil—psoriasis	0.000326	0.000782	CcSEcCtD
Trifluoperazine—Pruritus—Mycophenolate mofetil—psoriasis	0.000321	0.000771	CcSEcCtD
Trifluoperazine—Insomnia—Dexamethasone—psoriasis	0.000319	0.000767	CcSEcCtD
Trifluoperazine—Insomnia—Betamethasone—psoriasis	0.000319	0.000767	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—psoriasis	0.000315	0.000757	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisolone—psoriasis	0.000312	0.000749	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisone—psoriasis	0.000311	0.0159	CbGdCrCtD
Trifluoperazine—Urticaria—Triamcinolone—psoriasis	0.000309	0.000743	CcSEcCtD
Trifluoperazine—Body temperature increased—Triamcinolone—psoriasis	0.000308	0.000739	CcSEcCtD
Trifluoperazine—Dizziness—Cyclosporine—psoriasis	0.000308	0.000739	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisone—psoriasis	0.000308	0.000739	CcSEcCtD
Trifluoperazine—Decreased appetite—Dexamethasone—psoriasis	0.000307	0.000738	CcSEcCtD
Trifluoperazine—Decreased appetite—Betamethasone—psoriasis	0.000307	0.000738	CcSEcCtD
Trifluoperazine—Hypersensitivity—Hydrocortisone—psoriasis	0.000305	0.000732	CcSEcCtD
Trifluoperazine—Fatigue—Dexamethasone—psoriasis	0.000305	0.000732	CcSEcCtD
Trifluoperazine—Fatigue—Betamethasone—psoriasis	0.000305	0.000732	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisolone—psoriasis	0.000304	0.0155	CbGdCrCtD
Trifluoperazine—Dizziness—Mycophenolate mofetil—psoriasis	0.0003	0.000721	CcSEcCtD
Trifluoperazine—Skin disorder—Prednisone—psoriasis	0.000299	0.000718	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—psoriasis	0.000297	0.000713	CcSEcCtD
Trifluoperazine—Asthenia—Hydrocortisone—psoriasis	0.000297	0.000713	CcSEcCtD
Trifluoperazine—Rash—Cyclosporine—psoriasis	0.000293	0.000705	CcSEcCtD
Trifluoperazine—Anorexia—Prednisone—psoriasis	0.000293	0.000704	CcSEcCtD
Trifluoperazine—Dermatitis—Cyclosporine—psoriasis	0.000293	0.000704	CcSEcCtD
Trifluoperazine—Pruritus—Hydrocortisone—psoriasis	0.000292	0.000703	CcSEcCtD
Trifluoperazine—Headache—Cyclosporine—psoriasis	0.000291	0.0007	CcSEcCtD
Trifluoperazine—Hypersensitivity—Triamcinolone—psoriasis	0.000287	0.000689	CcSEcCtD
Trifluoperazine—Rash—Mycophenolate mofetil—psoriasis	0.000286	0.000687	CcSEcCtD
Trifluoperazine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000286	0.000687	CcSEcCtD
Trifluoperazine—Headache—Mycophenolate mofetil—psoriasis	0.000284	0.000683	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—psoriasis	0.000282	0.000677	CcSEcCtD
Trifluoperazine—Urticaria—Dexamethasone—psoriasis	0.000281	0.000674	CcSEcCtD
Trifluoperazine—Urticaria—Betamethasone—psoriasis	0.000281	0.000674	CcSEcCtD
Trifluoperazine—Dizziness—Prednisolone—psoriasis	0.00028	0.000672	CcSEcCtD
Trifluoperazine—Asthenia—Triamcinolone—psoriasis	0.000279	0.000671	CcSEcCtD
Trifluoperazine—Body temperature increased—Dexamethasone—psoriasis	0.000279	0.000671	CcSEcCtD
Trifluoperazine—Body temperature increased—Betamethasone—psoriasis	0.000279	0.000671	CcSEcCtD
Trifluoperazine—Insomnia—Prednisone—psoriasis	0.000278	0.000668	CcSEcCtD
Trifluoperazine—Nausea—Cyclosporine—psoriasis	0.000276	0.000664	CcSEcCtD
Trifluoperazine—Pruritus—Triamcinolone—psoriasis	0.000275	0.000662	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—psoriasis	0.000275	0.00066	CcSEcCtD
Trifluoperazine—Dizziness—Hydrocortisone—psoriasis	0.000273	0.000657	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—psoriasis	0.000273	0.000656	CcSEcCtD
Trifluoperazine—Nausea—Mycophenolate mofetil—psoriasis	0.00027	0.000648	CcSEcCtD
Trifluoperazine—Decreased appetite—Prednisone—psoriasis	0.000267	0.000642	CcSEcCtD
Trifluoperazine—Rash—Prednisolone—psoriasis	0.000267	0.000641	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisolone—psoriasis	0.000267	0.000641	CcSEcCtD
Trifluoperazine—Fatigue—Prednisone—psoriasis	0.000265	0.000637	CcSEcCtD
Trifluoperazine—Headache—Prednisolone—psoriasis	0.000265	0.000637	CcSEcCtD
Trifluoperazine—Constipation—Prednisone—psoriasis	0.000263	0.000632	CcSEcCtD
Trifluoperazine—Rash—Hydrocortisone—psoriasis	0.000261	0.000626	CcSEcCtD
Trifluoperazine—Dermatitis—Hydrocortisone—psoriasis	0.00026	0.000626	CcSEcCtD
Trifluoperazine—Headache—Hydrocortisone—psoriasis	0.000259	0.000622	CcSEcCtD
Trifluoperazine—Dizziness—Triamcinolone—psoriasis	0.000257	0.000618	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—psoriasis	0.000257	0.000618	CcSEcCtD
Trifluoperazine—Asthenia—Betamethasone—psoriasis	0.000253	0.000609	CcSEcCtD
Trifluoperazine—Asthenia—Dexamethasone—psoriasis	0.000253	0.000609	CcSEcCtD
Trifluoperazine—Nausea—Prednisolone—psoriasis	0.000251	0.000604	CcSEcCtD
Trifluoperazine—Pruritus—Dexamethasone—psoriasis	0.00025	0.0006	CcSEcCtD
Trifluoperazine—Pruritus—Betamethasone—psoriasis	0.00025	0.0006	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—psoriasis	0.00025	0.0006	CcSEcCtD
Trifluoperazine—Nausea—Hydrocortisone—psoriasis	0.000246	0.00059	CcSEcCtD
Trifluoperazine—Rash—Triamcinolone—psoriasis	0.000245	0.00059	CcSEcCtD
Trifluoperazine—Dermatitis—Triamcinolone—psoriasis	0.000245	0.000589	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—psoriasis	0.000245	0.000589	CcSEcCtD
Trifluoperazine—Urticaria—Prednisone—psoriasis	0.000244	0.000587	CcSEcCtD
Trifluoperazine—Headache—Triamcinolone—psoriasis	0.000244	0.000586	CcSEcCtD
Trifluoperazine—Body temperature increased—Prednisone—psoriasis	0.000243	0.000584	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—psoriasis	0.00024	0.000577	CcSEcCtD
Trifluoperazine—Dizziness—Dexamethasone—psoriasis	0.000234	0.000561	CcSEcCtD
Trifluoperazine—Dizziness—Betamethasone—psoriasis	0.000234	0.000561	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—psoriasis	0.000233	0.000559	CcSEcCtD
Trifluoperazine—Nausea—Triamcinolone—psoriasis	0.000231	0.000555	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—psoriasis	0.000229	0.000551	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—psoriasis	0.000229	0.000549	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisone—psoriasis	0.000227	0.000544	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—psoriasis	0.000223	0.000537	CcSEcCtD
Trifluoperazine—Rash—Dexamethasone—psoriasis	0.000223	0.000535	CcSEcCtD
Trifluoperazine—Rash—Betamethasone—psoriasis	0.000223	0.000535	CcSEcCtD
Trifluoperazine—Dermatitis—Dexamethasone—psoriasis	0.000223	0.000535	CcSEcCtD
Trifluoperazine—Dermatitis—Betamethasone—psoriasis	0.000223	0.000535	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—psoriasis	0.000222	0.000532	CcSEcCtD
Trifluoperazine—Headache—Dexamethasone—psoriasis	0.000221	0.000532	CcSEcCtD
Trifluoperazine—Headache—Betamethasone—psoriasis	0.000221	0.000532	CcSEcCtD
Trifluoperazine—Asthenia—Prednisone—psoriasis	0.000221	0.00053	CcSEcCtD
Trifluoperazine—Pruritus—Prednisone—psoriasis	0.000218	0.000523	CcSEcCtD
Trifluoperazine—Nausea—Dexamethasone—psoriasis	0.00021	0.000504	CcSEcCtD
Trifluoperazine—Nausea—Betamethasone—psoriasis	0.00021	0.000504	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—psoriasis	0.000204	0.000491	CcSEcCtD
Trifluoperazine—Dizziness—Prednisone—psoriasis	0.000203	0.000489	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—psoriasis	0.000203	0.000488	CcSEcCtD
Trifluoperazine—Rash—Prednisone—psoriasis	0.000194	0.000466	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisone—psoriasis	0.000194	0.000466	CcSEcCtD
Trifluoperazine—Headache—Prednisone—psoriasis	0.000193	0.000463	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—psoriasis	0.000189	0.000455	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—psoriasis	0.000184	0.000443	CcSEcCtD
Trifluoperazine—Nausea—Prednisone—psoriasis	0.000183	0.000439	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—psoriasis	0.000182	0.000437	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—psoriasis	0.00017	0.000408	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—psoriasis	0.000162	0.000389	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—psoriasis	0.000162	0.000389	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—psoriasis	0.000161	0.000387	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—psoriasis	0.000153	0.000367	CcSEcCtD
Trifluoperazine—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.000145	0.00741	CbGdCrCtD
Trifluoperazine—HTR2A—Signaling Pathways—SOCS1—psoriasis	2.71e-05	0.000191	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SOCS1—psoriasis	2.7e-05	0.000191	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.69e-05	0.00019	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SOCS1—psoriasis	2.66e-05	0.000188	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-A—psoriasis	2.66e-05	0.000188	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-A—psoriasis	2.66e-05	0.000188	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	2.65e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—VEGFA—psoriasis	2.64e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—JUN—psoriasis	2.63e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—JUN—psoriasis	2.63e-05	0.000186	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—TYK2—psoriasis	2.62e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CRP—psoriasis	2.62e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—NFKB1—psoriasis	2.62e-05	0.000185	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	2.6e-05	0.000184	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	2.59e-05	0.000183	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—TYK2—psoriasis	2.58e-05	0.000182	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—TYK2—psoriasis	2.57e-05	0.000182	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—VEGFA—psoriasis	2.55e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—VEGFA—psoriasis	2.55e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CAT—psoriasis	2.55e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HLA-A—psoriasis	2.54e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CRP—psoriasis	2.53e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CRP—psoriasis	2.53e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—TYK2—psoriasis	2.53e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—NFKB1—psoriasis	2.53e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—NFKB1—psoriasis	2.53e-05	0.000179	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	2.53e-05	0.000178	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	2.51e-05	0.000178	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—NFKB1—psoriasis	2.51e-05	0.000178	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CARM1—psoriasis	2.51e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-DRB1—psoriasis	2.51e-05	0.000177	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	2.47e-05	0.000175	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	2.47e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CAT—psoriasis	2.47e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CAT—psoriasis	2.47e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HLA-A—psoriasis	2.45e-05	0.000173	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HLA-A—psoriasis	2.45e-05	0.000173	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—NFKB1—psoriasis	2.43e-05	0.000172	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—NFKB1—psoriasis	2.43e-05	0.000172	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	2.43e-05	0.000172	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-DRB1—psoriasis	2.43e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-DRB1—psoriasis	2.43e-05	0.000171	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	2.42e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ICAM1—psoriasis	2.41e-05	0.00017	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—NFKBIA—psoriasis	2.39e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TYK2—psoriasis	2.38e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—APOE—psoriasis	2.37e-05	0.000167	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.35e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ICAM1—psoriasis	2.33e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ICAM1—psoriasis	2.33e-05	0.000165	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—LEP—psoriasis	2.31e-05	0.000163	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—APOE—psoriasis	2.31e-05	0.000163	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—NFKBIA—psoriasis	2.31e-05	0.000163	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—NFKBIA—psoriasis	2.31e-05	0.000163	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—APOE—psoriasis	2.3e-05	0.000162	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—LEP—psoriasis	2.3e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—APOE—psoriasis	2.29e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—APOE—psoriasis	2.29e-05	0.000162	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CXCL8—psoriasis	2.28e-05	0.000161	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	2.25e-05	0.000159	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SOCS1—psoriasis	2.25e-05	0.000159	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CXCL8—psoriasis	2.24e-05	0.000158	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS2—psoriasis	2.21e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	2.21e-05	0.000156	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	2.2e-05	0.000155	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SOCS1—psoriasis	2.17e-05	0.000154	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SOCS1—psoriasis	2.17e-05	0.000154	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	2.15e-05	0.000152	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	2.14e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—TYK2—psoriasis	2.14e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS2—psoriasis	2.13e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS2—psoriasis	2.13e-05	0.000151	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CXCL8—psoriasis	2.08e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—TYK2—psoriasis	2.07e-05	0.000146	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—TYK2—psoriasis	2.07e-05	0.000146	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—APOE—psoriasis	2.03e-05	0.000143	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—LEP—psoriasis	2.03e-05	0.000143	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—LEP—psoriasis	2e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—APOE—psoriasis	2e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—psoriasis	1.99e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—LEP—psoriasis	1.99e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APOE—psoriasis	1.99e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—APOE—psoriasis	1.98e-05	0.00014	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—psoriasis	1.97e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—LEP—psoriasis	1.96e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APOE—psoriasis	1.96e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—TYK2—psoriasis	1.96e-05	0.000138	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APOE—psoriasis	1.96e-05	0.000138	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—LEP—psoriasis	1.96e-05	0.000138	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CAT—psoriasis	1.93e-05	0.000137	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—JUN—psoriasis	1.93e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—psoriasis	1.93e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—psoriasis	1.93e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—APOE—psoriasis	1.92e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—APOE—psoriasis	1.92e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—TYK2—psoriasis	1.89e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—TYK2—psoriasis	1.89e-05	0.000134	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.89e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CXCL8—psoriasis	1.87e-05	0.000132	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.86e-05	0.000131	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—NFKB1—psoriasis	1.86e-05	0.000131	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.86e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNG—psoriasis	1.83e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	1.83e-05	0.000129	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	1.82e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TYK2—psoriasis	1.81e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CXCL8—psoriasis	1.8e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CXCL8—psoriasis	1.8e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNG—psoriasis	1.77e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNG—psoriasis	1.77e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD4—psoriasis	1.77e-05	0.000125	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TYK2—psoriasis	1.76e-05	0.000125	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TYK2—psoriasis	1.76e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TYK2—psoriasis	1.75e-05	0.000123	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TYK2—psoriasis	1.75e-05	0.000123	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PPARG—psoriasis	1.73e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD4—psoriasis	1.71e-05	0.000121	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD4—psoriasis	1.71e-05	0.000121	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—psoriasis	1.69e-05	0.000119	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PPARG—psoriasis	1.67e-05	0.000118	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PPARG—psoriasis	1.67e-05	0.000118	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—STAT3—psoriasis	1.67e-05	0.000118	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—psoriasis	1.66e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LEP—psoriasis	1.66e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—psoriasis	1.64e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD4—psoriasis	1.63e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—psoriasis	1.6e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—psoriasis	1.6e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LEP—psoriasis	1.6e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LEP—psoriasis	1.6e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—psoriasis	1.59e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—psoriasis	1.59e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—JUN—psoriasis	1.58e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD4—psoriasis	1.58e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD4—psoriasis	1.58e-05	0.000112	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TYK2—psoriasis	1.55e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NFKBIA—psoriasis	1.54e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAT—psoriasis	1.54e-05	0.000109	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.54e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—JUN—psoriasis	1.53e-05	0.000108	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—JUN—psoriasis	1.53e-05	0.000108	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.53e-05	0.000108	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—NFKB1—psoriasis	1.52e-05	0.000108	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TYK2—psoriasis	1.52e-05	0.000108	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TYK2—psoriasis	1.52e-05	0.000107	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—psoriasis	1.5e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TYK2—psoriasis	1.5e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NFKBIA—psoriasis	1.49e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NFKBIA—psoriasis	1.49e-05	0.000106	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TYK2—psoriasis	1.49e-05	0.000105	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—NFKB1—psoriasis	1.48e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—NFKB1—psoriasis	1.48e-05	0.000104	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—psoriasis	1.46e-05	0.000103	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—psoriasis	1.45e-05	0.000103	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—JUN—psoriasis	1.43e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—JUN—psoriasis	1.42e-05	0.0001	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.37e-05	9.71e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—STAT3—psoriasis	1.37e-05	9.68e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NFKB1—psoriasis	1.37e-05	9.66e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.35e-05	9.53e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	1.33e-05	9.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—STAT3—psoriasis	1.33e-05	9.36e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—STAT3—psoriasis	1.33e-05	9.36e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCL8—psoriasis	1.32e-05	9.36e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—psoriasis	1.31e-05	9.25e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCL8—psoriasis	1.3e-05	9.21e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	1.3e-05	9.18e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—psoriasis	1.28e-05	9.06e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—psoriasis	1.27e-05	9e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TYK2—psoriasis	1.27e-05	8.94e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—psoriasis	1.27e-05	8.94e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—psoriasis	1.26e-05	8.92e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—psoriasis	1.26e-05	8.9e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—JUN—psoriasis	1.25e-05	8.86e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.25e-05	8.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—psoriasis	1.24e-05	8.77e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—psoriasis	1.24e-05	8.75e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—psoriasis	1.24e-05	8.73e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.24e-05	8.73e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—JUN—psoriasis	1.23e-05	8.72e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—JUN—psoriasis	1.23e-05	8.7e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—psoriasis	1.23e-05	8.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TYK2—psoriasis	1.22e-05	8.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TYK2—psoriasis	1.22e-05	8.65e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—psoriasis	1.22e-05	8.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—psoriasis	1.22e-05	8.65e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—JUN—psoriasis	1.21e-05	8.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—JUN—psoriasis	1.21e-05	8.53e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.21e-05	8.53e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—psoriasis	1.2e-05	8.47e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	1.19e-05	8.39e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NFKB1—psoriasis	1.19e-05	8.37e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NFKB1—psoriasis	1.17e-05	8.24e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—psoriasis	1.17e-05	8.24e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	1.16e-05	8.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—psoriasis	1.1e-05	7.78e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.1e-05	7.74e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—psoriasis	1.08e-05	7.66e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	1.08e-05	7.62e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—psoriasis	1.08e-05	7.6e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—psoriasis	1.07e-05	7.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—psoriasis	1.07e-05	7.53e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—psoriasis	1.07e-05	7.53e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—psoriasis	1.07e-05	7.52e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—psoriasis	1.06e-05	7.48e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	1.06e-05	7.46e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—psoriasis	1.05e-05	7.4e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—psoriasis	1.05e-05	7.4e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—psoriasis	1.05e-05	7.38e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—psoriasis	1.04e-05	7.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—psoriasis	1.02e-05	7.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—psoriasis	1.01e-05	7.16e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—psoriasis	1.01e-05	7.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—psoriasis	9.91e-06	7e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—psoriasis	9.91e-06	7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NFKB1—psoriasis	9.86e-06	6.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—psoriasis	9.57e-06	6.76e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NFKB1—psoriasis	9.54e-06	6.74e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NFKB1—psoriasis	9.54e-06	6.74e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—psoriasis	9.43e-06	6.66e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—psoriasis	9.38e-06	6.63e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—psoriasis	9.26e-06	6.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—psoriasis	9.26e-06	6.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—psoriasis	8.95e-06	6.32e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—psoriasis	8.86e-06	6.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—psoriasis	8.84e-06	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—psoriasis	8.66e-06	6.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—psoriasis	8.66e-06	6.11e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—psoriasis	8.63e-06	6.1e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—psoriasis	8.59e-06	6.07e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—psoriasis	8.57e-06	6.05e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—psoriasis	8.57e-06	6.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—psoriasis	8.55e-06	6.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—psoriasis	8.55e-06	6.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—psoriasis	8.28e-06	5.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—psoriasis	8.14e-06	5.75e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—psoriasis	8.13e-06	5.74e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—psoriasis	8e-06	5.65e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—psoriasis	7.98e-06	5.63e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—psoriasis	7.58e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—psoriasis	7.46e-06	5.27e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—psoriasis	7.44e-06	5.26e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—psoriasis	7.32e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—psoriasis	7.3e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—psoriasis	6.76e-06	4.78e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—psoriasis	6.54e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—psoriasis	6.54e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—psoriasis	6.19e-06	4.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—psoriasis	5.99e-06	4.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—psoriasis	5.99e-06	4.23e-05	CbGpPWpGaD
